Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MDM4 | O15151 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | CASP3 | P42574 | 2/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29354378 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL30338216 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL12254866 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL29400089 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL1025352 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL14997839 | 1.00 | KMT2A (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL12658035 | 0.95 | PTPN1 (0.58) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL14719947 | 0.93 | KMT2A (0.57) | KMT2AMDM4TP53TLR2CASP3 | |
| SCHEMBL22712859 | 0.93 | TLR2 (0.54) | KMT2AMDM4TP53TLR2CASP3 | |
| D-Glutamate SCHEMBL28574794 | 0.93 | MDM4 (0.52) | KMT2AMDM4TP53TLR2CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005719-A | SIRP alpha blocker polypeptide, construction method and application thereof | 华东理工大学 | 2024-05-10 | — | — | CN | claimed |
| US-20260116920-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | PEPTIDREAM INC. (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4731602-A1 | NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS | OZ Biosciences (FR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4608451-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | Genmab A/S (DK) | 2025-09-03 | — | — | EP | disclosed |
| EP-4585609-A1 | RGD DIMER COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Yantai Lannacheng Biotechnology Co., Ltd. (CN) | 2025-07-16 | — | — | EP | disclosed |
| US-20250161504-A1 | RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | YANTAI LANNACHENG BIOTECHNOLOGY CO., LTD. (CN) | 2025-05-22 | — | — | US | disclosed |
| CN-119955106-A | Amino acid-containing polyethylene glycol block polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20250041306-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | EUBULUS BIOTHERAPEUTICS INC. (CN) | 2025-02-06 | — | — | US | disclosed |
| CN-119330800-A | Method for directly synthesizing beta-acyloxy enamide compound by three components and application thereof | 江西师范大学 | 2025-01-21 | — | — | CN | disclosed |
| WO-2024261311-A1 | NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS | OZ BIOSCIENCES (FR) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024092067-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-113454058-B | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-110869544-B | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-116606348-A | Self-assembled supermolecule nano material responding to AXL kinase and preparation method and application thereof | 东南大学 | 2023-08-18 | — | — | CN | disclosed |
| WO-2023022234-A1 | HUMAN TRANSFERRIN RECEPTOR–BINDING PEPTIDE | ペプチドリーム株式会社 | 2023-02-23 | — | — | WO | disclosed |
| CN-115433261-B | RGD dimer compound and preparation method and application thereof | 烟台蓝纳成生物技术有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-115433261-A | RGD dimer compound and preparation method and application thereof | 烟台蓝纳成生物技术有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-115340472-A | Glutamic acid derivative and synthetic method and application thereof | 合肥工业大学 | 2022-11-15 | — | — | CN | disclosed |
| WO-2022234852-A1 | PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND | 中外製薬株式会社 | 2022-11-10 | — | — | WO | disclosed |
| CN-115053184-A | Composition for forming EUV resist underlayer film | 日产化学株式会社 | 2022-09-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041306-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | ADAMTS1, UCHL3, ADAM33 | KMT2A 2414/4885MDM4 2326/4885TP53 466/4885 |
| US-20260116920-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | MET, TFRC, SLC7A1 | KMT2A 2183/4885MDM4 1622/4885TP53 2215/4885 |
| US-20250161504-A1 | RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | ITGAV, ITGB7, ITGB1 | KMT2A 4133/4885MDM4 3042/4885TP53 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.